[ASAP] Development of Novel 111In/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics 🔗 Access full article via ACS Journal of Medicinal Chemistry Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.3c00346 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
